Literature DB >> 23575349

The backscatter electron signal as an additional tool for phase segmentation in electron backscatter diffraction.

E J Payton1, G Nolze.   

Abstract

The advent of simultaneous energy dispersive X-ray spectroscopy (EDS) data collection has vastly improved the phase separation capabilities for electron backscatter diffraction (EBSD) mapping. A major problem remains, however, in distinguishing between multiple cubic phases in a specimen, especially when the compositions of the phases are similar or their particle sizes are small, because the EDS interaction volume is much larger than that of EBSD and the EDS spectra collected during spatial mapping are generally noisy due to time limitations and the need to minimize sample drift. The backscatter electron (BSE) signal is very sensitive to the local composition due to its atomic number (Z) dependence. BSE imaging is investigated as a complimentary tool to EDS to assist phase segmentation and identification in EBSD through examination of specimens of meteorite, Cu dross, and steel oxidation layers. The results demonstrate that the simultaneous acquisition of EBSD patterns, EDS spectra, and the BSE signal can provide new potential for advancing multiphase material characterization in the scanning electron microscope.

Year:  2013        PMID: 23575349     DOI: 10.1017/S1431927613000305

Source DB:  PubMed          Journal:  Microsc Microanal        ISSN: 1431-9276            Impact factor:   4.127


  2 in total

1.  Polynomial fitting method of background correction for electron backscatter diffraction patterns.

Authors:  Yi-Yun Tsai; Yi-Chen Pan; Jui-Chao Kuo
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

2.  Quantitative imaging of anti-phase domains by polarity sensitive orientation mapping using electron backscatter diffraction.

Authors:  G Naresh-Kumar; A Vilalta-Clemente; H Jussila; A Winkelmann; G Nolze; S Vespucci; S Nagarajan; A J Wilkinson; C Trager-Cowan
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.